Pfizer's Read taps new pharma managers

Pfizer's pharma division has a new leadership team, assembled by its chief Ian Read (photo). It's part of the company's realignment into global business units, dubbed "Our Path Forward." Ed Silverman at Pharmalot has Read's memo and the slate of new managers. Report

Suggested Articles

Alnylam is ready to follow on its Onpattro launch with an FDA nod for Givlaari. But the drug's safety profile is giving analysts reason to pause.

FDA nominee Stephen Hahn faced questions from Senators on Wednesday on topics including drug pricing, biosimilars, opioids and more.

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.